Schwartz Joins Biotechnology Industry Organization (BIO) and Pennsylvania Bio to Discuss the Importance of the Therapeutic Tax Credit for Small Biotech Firms  
7/26/2010 8:09:44 AM

--(BUSINESS WIRE)--On Monday, July 26th, U.S. Rep. Allyson Schwartz, Jim Greenwood, president and CEO of the Biotechnology Industry Organization (BIO), and Christopher Molineaux, president of Pennsylvania Bio, will host a roundtable discussion on the new Therapeutic Discovery Project Program. This new program offers small biotech companies (less than 250 employees) a tax credit or grant to encourage investment in new medical therapies for life-changing diseases.